ICCC: Target konsensus ImmuCell Corp

This chart of ImmuCell Corporation (ICCC) price action illustrates the dynamics of an asset whose revenue is based on the sale of veterinary biologicals, including the key First Defense line for calves. Due to a lack of competitors in the over-the-counter livestock immune support sector, the company maintains significant pricing power, reaching a value of 0.00. Meanwhile, production strictly adheres to environmental standards for chemical waste processing and wastewater treatment.

To identify fundamental stability drivers, an investor must compare the current price with the target market consensus—the arithmetic mean of expert forecasts—to determine the margin of safety. This gap allows for an assessment of the fair market value of ImmuCell Corporation (ICCC), given the high level of confidence among US farmers in the efficacy of the company's veterinary developments in livestock health protection.